RT Journal Article SR Electronic T1 Demonstrating multi-country calibration of a tuberculosis model using new history matching and emulation package - hmer JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2022.05.13.22275052 DO 10.1101/2022.05.13.22275052 A1 Danny Scarponi A1 Andrew Iskauskas A1 Rebecca A Clark A1 Ian Vernon A1 Trevelyan J. McKinley A1 Michael Goldstein A1 Christinah Mukandavire A1 Arminder Deol A1 Chathika Weerasuriya A1 Roel Bakker A1 Richard G White A1 Nicky McCreesh YR 2022 UL http://medrxiv.org/content/early/2022/05/16/2022.05.13.22275052.abstract AB Infectious disease models are widely used by epidemiologists to improve the understanding of transmission dynamics and disease natural history, and to predict the possible effects of interventions. As the complexity of such models increases, however, it becomes increasingly challenging to robustly calibrate them to empirical data. History matching with emulation is a calibration method that has been successfully applied to such models, but has not been widely used in epidemiology partly due to the lack of available software. To address this issue, we developed a new, user-friendly R package hmer to simply and efficiently perform history matching with emulation. In this paper, we demonstrate the first use of hmer for calibrating a complex deterministic model for the country-level implementation of tuberculosis vaccines to 115 low- and middle-income countries. The model was fit to 9–13 target measures, by varying 19–22 input parameters. Overall, 105 countries were successfully calibrated. Among the remaining countries, hmer visualisation tools, combined with derivative emulation methods, provided strong evidence that the models were misspecified and could not be calibrated to the target ranges. This work shows that hmer can be used to simply and rapidly calibrate a complex model to data from over 100 countries, making it a useful addition to the epidemiologist’s calibration tool-kit.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by Wellcome Trust (218261/Z/19/Z) and WHO (2020/985800-0).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:WHO database and UN population estimatesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.